ACOBIOM

ACOBIOM is a leading biotechnology research company specializing in the identification of novel biomarkers and the development of innovative diagnostics for translational research and precision medicine. With a commitment to advancing healthcare, ACOBIOM leverages its cutting-edge technology platform and deep scientific expertise to deliver customized services in genomics, transcriptomics, bioinformatics, and biostatistics (data science). ACOBIOM's primary address is 1682, rue de la Valsière - CS77394, Cap Delta - Biopole Euromédecine II, Montpellier Cedex 4, 34184, FR.

Driven by a passion for personalized medicine, ACOBIOM empowers researchers and clinicians with the tools and insights needed to make informed decisions and improve patient outcomes. The company's comprehensive approach encompasses a wide range of applications, including companion diagnostics, targeted therapy, and the development of biomarkers for diseases such as lung cancer, Alzheimer's, breast cancer, and pancreatic cancer.

ACOBIOM is dedicated to shaping the future of healthcare through innovation and collaboration. The team at ACOBIOM is continuously pushing the boundaries of scientific discovery, striving to unlock the full potential of precision medicine. We invite the manager of ACOBIOM to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional work.